Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Respiratory Distress Syndrome, Adult
0.080 Biomarker disease BEFREE Surfactant based on a recombinant surfactant protein C analogue (rSP-C33Leu) is easy to produce and in this study we compared its effects on lung function and inflammation with a commercial surfactant preparation in an adult rabbit model of ARDS. 31694668 2019
Respiratory Distress Syndrome, Adult
0.080 Biomarker disease BEFREE This study focuses on a new mechanism of SPC as an anti-inflammatory molecule using SPC-TK/SPC-KO (surfactant protein C-thymidine kinase/surfactant protein C knockout) mice, which represent a novel sterile injury model that mimics clinical acute respiratory distress syndrome (ARDS). 29345196 2018
Respiratory Distress Syndrome, Adult
0.080 Biomarker disease BEFREE CHF5633 is a new generation synthetic surfactant containing both SP-B and SP-C analogues developed for the treatment of respiratory distress syndrome. 27973472 2017
Respiratory Distress Syndrome, Adult
0.080 Biomarker disease BEFREE A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome. 28465315 2017
Respiratory Distress Syndrome, Adult
0.080 AlteredExpression disease BEFREE Expression of SP-C and Ki67 in lungs of preterm infants dying from respiratory distress syndrome. 23027351 2012
Respiratory Distress Syndrome, Adult
0.080 Biomarker disease BEFREE The BRICHOS domain was initially defined from sequence alignments of the Bri protein associated with familial dementia, chondromodulin associated with chondrosarcoma and surfactant protein C precursor (proSP-C) associated with respiratory distress syndrome and interstitial lung disease (ILD). 21668643 2011
Respiratory Distress Syndrome, Adult
0.080 GeneticVariation disease BEFREE Our data provide evidence that ABCA3 mutations are associated not only with a deficiency of ABCA3 but also with an abnormal processing and routing of SP-B and SP-C, leading to severe alterations of surfactant homeostasis and respiratory distress syndrome. 16728712 2006
Respiratory Distress Syndrome, Adult
0.080 Biomarker disease BEFREE Surfactant replacement therapy with bovine and porcine lung surfactant extracts, which contain only polar lipids and SP-B and SP-C, has revolutionized the clinical management of premature infants with respiratory distress syndrome. 11001826 2000